Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ENDO INTERNATIONAL PLC ENDPQ

Healthcare Drug Manufacturers - Specialty & Generic
Endo International plc has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code and is winding down its business. The Company has no business operations.

Recent & Breaking News (GREY:ENDPQ)

Endo Completes Divestiture of American Medical Systems' Men's and Prostate Health Businesses to Boston Scientific

Canada NewsWire August 4, 2015

Endo Completes Divestiture of American Medical Systems' Men's and Prostate Health Businesses to Boston Scientific

Canada NewsWire August 4, 2015

Endo Completes Divestiture of American Medical Systems' Men's and Prostate Health Businesses to Boston Scientific

Canada NewsWire August 4, 2015

Endo to Announce Second Quarter 2015 Financial Results on August 10, 2015

Canada NewsWire July 27, 2015

Endo to Announce Second Quarter 2015 Financial Results on August 10, 2015

Canada NewsWire July 27, 2015

Endo International plc Announces Conditional Redemption of All $499,875,000 Aggregate Principal Amount Outstanding of the Two Series of 7.00% Senior Notes due 2019

Canada NewsWire June 24, 2015

Endo International plc Announces Pricing of Private Offering Of Senior Notes

Canada NewsWire June 24, 2015

Endo International plc Announces Proposed Private Offering Of Senior Notes

Canada NewsWire June 19, 2015

Endo International plc Closes Offering of 27,627,628 Ordinary Shares

Canada NewsWire June 10, 2015

ARIAD and Paladin Announce Commercial Distribution Agreement for Iclusig (Ponatinib) in Canada

Business Wire June 10, 2015

Endo International plc Prices Offering of 24,024,025 Ordinary Shares

Canada NewsWire June 4, 2015

Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares

Canada NewsWire June 2, 2015

First Ever Peyronie's Disease (PD) Treatment Guidelines Support Use of XIAFLEX® in Appropriate Patients

PR Newswire May 19, 2015

Endo to Acquire Par Pharmaceutical, Strategically Expanding Generics Business to a Top 5 Industry Leader

Canada NewsWire May 18, 2015

Endo Announces Updated XIAFLEX® Label with Recurrence and Retreatment Data in Patients with Dupuytren's Contracture

Canada NewsWire May 15, 2015

Endo Pharmaceuticals and BioDelivery Sciences Present Pivotal Data from Two Phase 3 Trials Demonstrating Safety and Efficacy of Buprenorphine HCl Buccal Film for the Management of Chronic Pain

Canada NewsWire May 14, 2015

Endo Employees Participate in 2nd Annual "Endo Gives" Day of Volunteering, Serving the Communities Where They Live and Work

Canada NewsWire May 14, 2015

Endo Acquires Broad Portfolio of Branded and Generic Products, Expanding International Pharmaceuticals Business

Canada NewsWire May 11, 2015

Endo Reports First Quarter 2015 Financial Results

Canada NewsWire May 11, 2015

Endo Announces Appearance at UBS Global Healthcare Conference

PR Newswire May 6, 2015